comparemela.com

Latest Breaking News On - Alexandre akoulitchev - Page 1 : comparemela.com

Oxford BioDynamics and Kings College London to advance rheumatoid arthritis treatment

Oxford BioDynamics (OBD) and King’s College London (KCL) have partnered to use OBD’s EpiSwitch technology to identify patients at risk of rheumatoid arthritis (RA) who can benefit from abatacept treatment.

United-kingdom
Alexandre-akoulitchev
Professor-andy
Oxford-biodynamics
Andrew-cope
Professor-cope
Bio-developments
Pipelines
Emerging-markets
Rheumatoid-arthritis
Clinical-trial

vimarsana © 2020. All Rights Reserved.